Interpretable habitat and peritumoral radiomics from multiparametric MRI for preoperative high-risk prostate cancer prediction: a multi-institutional study.
[BACKGROUND] Current preoperative assessment faces limitations, including PI-RADS scoring subjectivity and diagnostic uncertainty in distinguishing high-risk prostate cancer from benign and low-risk l
- p-value p < 0.001
- 95% CI 0.768-0.886
APA
Yuan M, Chang D, et al. (2026). Interpretable habitat and peritumoral radiomics from multiparametric MRI for preoperative high-risk prostate cancer prediction: a multi-institutional study.. Journal of translational medicine, 24(1). https://doi.org/10.1186/s12967-026-07848-1
MLA
Yuan M, et al.. "Interpretable habitat and peritumoral radiomics from multiparametric MRI for preoperative high-risk prostate cancer prediction: a multi-institutional study.." Journal of translational medicine, vol. 24, no. 1, 2026.
PMID
41691237
Abstract
[BACKGROUND] Current preoperative assessment faces limitations, including PI-RADS scoring subjectivity and diagnostic uncertainty in distinguishing high-risk prostate cancer from benign and low-risk lesions. To develop an interpretable ensemble learning framework integrating habitat-based radiomics and peritumoral analysis from multiparametric MRI for preoperative high-risk prostate cancer prediction.
[METHODS] This retrospective, multi-institutional study included 896 patients with suspected prostate lesions and histopathologically confirmed diagnoses across three centers (January 2018-December 2024). Intratumoral habitat analysis used K-means clustering; peritumoral analysis evaluated 1 mm, 3 mm, and 5 mm expansion rings. Feature selection used minimum Redundancy Maximum Relevance (mRMR) and LASSO regression. Models were validated externally with SHAP analysis for interpretability.
[RESULTS] The cohort comprised 398 training, 171 internal validation, and 327 external validation patients. The habitat signature achieved superior performance with AUCs of 0.827 (95% CI: 0.768-0.886) and 0.855 (95% CI: 0.795-0.915) in external validation cohorts, significantly outperforming intratumoral signatures (AUCs: 0.774 and 0.629, p < 0.001) and clinical signatures (AUCs: 0.791 and 0.712, p < 0.001). The 3 mm peritumoral signature performed best (AUC: 0.782-0.793). The combined model achieved the highest performance (AUC: 0.860-0.876). SHAP analysis showed ADC-derived features dominated importance, with habitat region H3 contributing > 70% of selected features.
[CONCLUSION] Integrated habitat and peritumoral radiomics provide robust preoperative risk stratification for prostate cancer, with superior performance from ADC-derived habitat features.
[TRIAL REGISTRATION] Not applicable. This was a retrospective observational study without prospective trial registration.
[METHODS] This retrospective, multi-institutional study included 896 patients with suspected prostate lesions and histopathologically confirmed diagnoses across three centers (January 2018-December 2024). Intratumoral habitat analysis used K-means clustering; peritumoral analysis evaluated 1 mm, 3 mm, and 5 mm expansion rings. Feature selection used minimum Redundancy Maximum Relevance (mRMR) and LASSO regression. Models were validated externally with SHAP analysis for interpretability.
[RESULTS] The cohort comprised 398 training, 171 internal validation, and 327 external validation patients. The habitat signature achieved superior performance with AUCs of 0.827 (95% CI: 0.768-0.886) and 0.855 (95% CI: 0.795-0.915) in external validation cohorts, significantly outperforming intratumoral signatures (AUCs: 0.774 and 0.629, p < 0.001) and clinical signatures (AUCs: 0.791 and 0.712, p < 0.001). The 3 mm peritumoral signature performed best (AUC: 0.782-0.793). The combined model achieved the highest performance (AUC: 0.860-0.876). SHAP analysis showed ADC-derived features dominated importance, with habitat region H3 contributing > 70% of selected features.
[CONCLUSION] Integrated habitat and peritumoral radiomics provide robust preoperative risk stratification for prostate cancer, with superior performance from ADC-derived habitat features.
[TRIAL REGISTRATION] Not applicable. This was a retrospective observational study without prospective trial registration.
MeSH Terms
Humans; Male; Prostatic Neoplasms; Multiparametric Magnetic Resonance Imaging; Middle Aged; Aged; Retrospective Studies; Risk Factors; Reproducibility of Results; Preoperative Period; Radiomics
같은 제1저자의 인용 많은 논문 (5)
- Platelet indices as prognostic biomarkers in lung cancer: A meta-analysis and Mendelian randomization study.
- ANKRD49 promotes the epithelial-mesenchymal transition of non-small cell lung cancer via the PKNOX1/TGF-β1/SMAD axis.
- Programmed death-ligand 1 (PD-L1) Modulates Chemokine Production Via the TLR4/TRAF6 Signaling Axis During LPS + IFN-γ-Induced Endotoxemia-mimicked Sepsis.
- PD-L1 as a Potential Inducer for NF-κB Pathway Activation in M1-Type Macrophages During Sepsis: An Integrated Analysis Based on GEO Public Database and Multi-Omics Data.
- Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation.